KALA
Price:
$6.7792
Market Cap:
$31.24M
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-07-20
Stock Exchange
NASDAQ
Ticker
KALA
According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.84M. This represents a change of 161.43% compared to the average of 5.29M of the last 4 quarters.
The mean historical Enterprise Value of Kala Pharmaceuticals, Inc. over the last ten years is 76.39M. The current 13.84M Enterprise Value has changed 1.71% with respect to the historical average. Over the past ten years (40 quarters), KALA's Enterprise Value was at its highest in in the June 2020 quarter at 558.48M. The Enterprise Value was at its lowest in in the December 2016 quarter at -32032946.35.
Average
76.39M
Median
31.73M
Minimum
-32032946.35
Maximum
378.77M
Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.80%
Maximum Annual Enterprise Value = 378.77M
Minimum Annual Increase = -509.57%
Minimum Annual Enterprise Value = -32032946.35
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.45M | -91.95% |
2022 | 30.47M | -54.49% |
2021 | 66.95M | -82.33% |
2020 | 378.77M | 166.80% |
2019 | 141.97M | 139.13% |
2018 | 59.37M | 87.11% |
2017 | 31.73M | -199.05% |
2016 | -32032946.35 | -509.57% |
The current Enterprise Value of Kala Pharmaceuticals, Inc. (KALA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
33.29M
5-year avg
124.12M
10-year avg
76.39M
Kala Pharmaceuticals, Inc.’s Enterprise Value is less than Mallinckrodt plc (2.62B), less than Lifecore Biomedical, Inc. (343.18M), greater than Lucy Scientific Discovery Inc. (2.06M), less than Alimera Sciences, Inc. (362.58M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Shuttle Pharmaceuticals Holdings, Inc. (5.38M), less than Journey Medical Corporation (109.68M), greater than Akanda Corp. (-3461700.00), less than Organogenesis Holdings Inc. (418.24M), greater than Biofrontera Inc. (2.66M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than China Pharma Holdings, Inc. (7.61M), less than Alkermes plc (4.21B), less than Neurocrine Biosciences, Inc. (12.10B), less than Intra-Cellular Therapies, Inc. (8.71B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Dynavax Technologies Corporation (1.69B),
Company | Enterprise Value | Market cap |
---|---|---|
2.62B | $4.52M | |
343.18M | $220.78M | |
2.06M | $906.91K | |
362.58M | $301.29M | |
-6593458674.00 | $7.25M | |
5.38M | $4.92M | |
109.68M | $110.79M | |
-3461700.00 | $2.20M | |
418.24M | $397.72M | |
2.66M | $5.60M | |
-10475955.00 | $4.35M | |
7.61M | $4.29M | |
4.21B | $4.32B | |
12.10B | $12.20B | |
8.71B | $9.15B | |
2.15B | $2.21B | |
1.69B | $1.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kala Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Kala Pharmaceuticals, Inc. (KALA)?
What is the 3-year average Enterprise Value for Kala Pharmaceuticals, Inc. (KALA)?
What is the 5-year average Enterprise Value for Kala Pharmaceuticals, Inc. (KALA)?
How does the current Enterprise Value for Kala Pharmaceuticals, Inc. (KALA) compare to its historical average?